BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33118161)

  • 1. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
    Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
    Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of dose-averaged linear energy transfer (LET
    Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
    Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
    Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
    Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
    Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
    Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
    Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
    J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
    An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
    Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
    Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
    Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton monoenergetic arc therapy (PMAT) to enhance LETd within the target.
    Bertolet A; Carabe A
    Phys Med Biol; 2020 Aug; 65(16):165006. PubMed ID: 32428896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LET trilemma: Conflicts between robust target coverage, uniform dose, and dose-averaged LET in carbon therapy.
    Fredriksson A; Glimelius L; Bokrantz R
    Med Phys; 2023 Dec; 50(12):7338-7348. PubMed ID: 37820319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
    Henry T; Ödén J
    Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust Optimization for Intensity Modulated Proton Therapy to Redistribute High Linear Energy Transfer from Nearby Critical Organs to Tumors in Head and Neck Cancer.
    Liu C; Patel SH; Shan J; Schild SE; Vargas CE; Wong WW; Ding X; Bues M; Liu W
    Int J Radiat Oncol Biol Phys; 2020 May; 107(1):181-193. PubMed ID: 31987967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation.
    Bolsi A; Placidi L; Pica A; Ahlhelm FJ; Walser M; Lomax AJ; Weber DC
    Radiother Oncol; 2020 Aug; 149():197-204. PubMed ID: 32387488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
    Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
    Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
    Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
    Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
    Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-planning approaches to intensity modulated proton therapy and the impact on dose-weighted linear energy transfer.
    Faught AM; Wilson LJ; Gargone M; Pirlepesov F; Moskvin VP; Hua CH
    J Appl Clin Med Phys; 2023 Jan; 24(1):e13782. PubMed ID: 36161765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
    Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
    Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRoG: An independent dose and LET
    Kopp B; Fuglsang Jensen M; Mein S; Hoffmann L; Nyström H; Falk M; Haberer T; Abdollahi A; Debus J; Mairani A
    Med Phys; 2020 Oct; 47(10):5274-5286. PubMed ID: 32737870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.